Are selectins involved in metastasis?

PubWeight™: 1.04‹?› | Rank: Top 15%

🔗 View Article (PMID 10432003)

Published in Clin Exp Metastasis on May 01, 1999

Authors

T Krause1, G A Turner

Author Affiliations

1: Department of Clinical Biochemistry, The Medical School, Newcastle upon Tyne, UK.

Articles citing this

Achievements and challenges of sialic acid research. Glycoconj J (2001) 2.24

Targeting selectins and selectin ligands in inflammation and cancer. Expert Opin Ther Targets (2007) 1.82

The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression. Glycoconj J (2007) 1.74

Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis (2007) 1.68

Sialyl Lewis(x)-mediated, PSGL-1-independent rolling adhesion on P-selectin. Biophys J (2000) 1.65

Increased primary tumor growth in mice null for beta3- or beta3/beta5-integrins or selectins. Proc Natl Acad Sci U S A (2004) 1.33

Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. Cancer Res (2009) 1.26

Evidence of porcine and human endothelium activation by cancer-associated carbohydrates expressed on glycoproteins and tumour cells. J Physiol (2004) 1.14

AB0 blood group and prognosis in patients with pancreatic cancer. BMC Cancer (2012) 1.06

Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis (2002) 1.02

Mac-2 binding protein is a novel E-selectin ligand expressed by breast cancer cells. PLoS One (2012) 0.99

HOXA9 participates in the transcriptional activation of E-selectin in endothelial cells. Mol Cell Biol (2007) 0.98

E-selectin liposomal and nanotube-targeted delivery of doxorubicin to circulating tumor cells. J Control Release (2012) 0.97

Nanostructured Surfaces to Target and Kill Circulating Tumor Cells While Repelling Leukocytes. J Nanomater (2012) 0.90

Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors. PLoS One (2011) 0.88

Sialylated Lewis x antigen bearing glycoproteins in human plasma. J Proteome Res (2010) 0.87

Inducing apoptosis in rolling cancer cells: a combined therapy with aspirin and immobilized TRAIL and E-selectin. Mol Pharm (2012) 0.86

CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions. Am J Physiol Cell Physiol (2014) 0.84

Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma. J Hematol Oncol (2016) 0.80

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma. BMC Cancer (2015) 0.79

Identification of Lectins from Metastatic Cancer Cells through Magnetic Glyconanoparticles. Isr J Chem (2015) 0.75

Articles cited by this

Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res (1996) 3.73

P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A (1998) 3.02

Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents. J Clin Invest (1998) 1.97

Selectin-carbohydrate interactions during inflammation and metastasis. Glycoconj J (1997) 1.65

Rolling and adhesion of human tumor cells on vascular endothelium under physiological flow conditions. J Clin Invest (1993) 1.56

Circulating intercellular adhesion molecule-1 (ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies. Br J Cancer (1993) 1.48

P-selectin mediates adhesion of platelets to neuroblastoma and small cell lung cancer. J Clin Invest (1993) 1.37

E-selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol (1996) 1.35

Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1alpha on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res (1997) 1.33

Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis. Gastroenterology (1996) 1.32

Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma. Cancer Res (1989) 1.32

Liver endothelial E-selectin mediates carcinoma cell adhesion and promotes liver metastasis. Int J Cancer (1997) 1.29

Redirection of tumor metastasis by expression of E-selectin in vivo. J Exp Med (1996) 1.27

A role for sialyl Lewis-X/A glycoconjugates in capillary morphogenesis. Nature (1993) 1.27

E-selectin-mediated dynamic interactions of breast- and colon-cancer cells with endothelial-cell monolayers. Int J Cancer (1995) 1.27

CD44 in inflammation and metastasis. Glycoconj J (1997) 1.16

Inhibition of colon carcinoma cell lung colony formation by a soluble form of E-selectin. Am J Pathol (1997) 1.12

Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis. Dis Colon Rectum (1997) 1.10

Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells. Biochem Biophys Res Commun (1996) 1.09

Importance of E-selectin (ELAM-1) and sialyl Lewis(a) in the adhesion of pancreatic carcinoma cells to activated endothelium. Int J Cancer (1993) 1.07

Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma. Int J Cancer (1997) 1.04

Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer (1996) 1.04

P-selectin expression in a metastatic pancreatic tumor cell line (SUIT-2). Cancer Res (1997) 1.01

Vascular expression of E-selectin is increased in estrogen-receptor-negative breast cancer: a role for tumor-cell-secreted interleukin-1 alpha. Am J Pathol (1997) 1.00

Endothelial leukocyte adhesion molecule-1-dependent adhesion of colon carcinoma cells to vascular endothelium is inhibited by an antibody to Lewis fucosylated type I carbohydrate chain. Lab Invest (1992) 0.99

Expression of E-selectin on endothelial cells of small veins in human colorectal cancer. Int J Cancer (1995) 0.98

A sialyl-Le(x)-negative melanoma cell line binds to E-selectin but not to P-selectin. Cancer Res (1994) 0.96

Circulating soluble adhesion molecules E-cadherin, E-selectin, intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) in patients with gastric cancer. Br J Cancer (1997) 0.96

The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumor endothelium. Breast Cancer Res Treat (1995) 0.94

Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur J Cancer (1996) 0.94

Effects of anti-nuclear factor kappa B reagents in blocking adhesion of human cancer cells to vascular endothelial cells. Cancer Res (1995) 0.93

Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res (1993) 0.93

Association with clinical outcome of expression of VLA-4 in primary cutaneous malignant melanoma as well as P-selectin and E-selectin on intratumoral vessels. J Natl Cancer Inst (1995) 0.92

The association of sialyl Lewis(a) antigen with the metastatic potential of human colon cancer cells. Anticancer Res (1998) 0.92

Adhesion molecules in lymphoma metastasis. Cancer Metastasis Rev (1991) 0.91

Expression of carbohydrate antigen sialyl Le(a): a new functional prognostic factor in gastric cancer. J Clin Oncol (1997) 0.90

P-selectin-mediated attachment of small cell lung carcinoma to endothelial cells. Am J Physiol (1996) 0.89

Tumor cell arrest in the microcirculation: lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo. Clin Immunol Immunopathol (1997) 0.89

Disialosyl galactosylgloboside as an adhesion molecule expressed on renal cell carcinoma and its relationship to metastatic potential. Cancer Res (1996) 0.88

A human colon carcinoma cell line exhibits adhesive interactions with P-selectin under fluid flow via a PSGL-1-independent mechanism. Am J Pathol (1996) 0.88

Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj J (1996) 0.87

Thrombin promotes platelet-mediated melanoma cell adhesion to endothelial cells under flow conditions: role of platelet glycoproteins P-selectin and GPIIb-IIIA. Br J Cancer (1998) 0.87

Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer (1997) 0.85

Selectin ligands on human melanoma cells. Glycoconj J (1996) 0.84

Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length. Int J Cancer (1998) 0.84

In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands. Glycoconj J (1997) 0.83

Expression of selectin ligands by cutaneous squamous cell carcinoma. Am J Pathol (1993) 0.83

Endothelial-selectin ligands sialyl Lewis(x) and sialyl Lewis(a) are differentiation antigens immunogenic in human melanoma. Cancer (1997) 0.82

Adhesion molecules in the dissemination of non-Hodgkin's lymphomas. Acta Haematol (1997) 0.82

The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer. Clin Cancer Res (1998) 0.81

The relative roles of vitronectin receptor, E-selectin and alpha 4 beta 1 in cancer cell adhesion to interleukin-1-treated endothelial cells. Eur J Cancer (1994) 0.81

P-selectin mediates adhesion of the human melanoma cell line NKI-4: identification of glycoprotein ligands. Biochemistry (1998) 0.81

Endothelial P-selectin expression is reduced in advanced primary melanoma and melanoma metastasis. Am J Pathol (1998) 0.80

VLA-4 integrin on sarcoma cell lines recognizes endothelial VCAM-1. Differential regulation of the VLA-4 avidity on various sarcoma cell lines. Int J Cancer (1992) 0.80

Functional role of sialyl Lewis X and fibronectin-derived RGDS peptide analogue on tumor-cell arrest in lungs followed by extravasation. Int J Cancer (1996) 0.79

E-selectin binds to squamous cell carcinoma and keratinocyte cell lines. J Invest Dermatol (1996) 0.79

The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer. Anticancer Res (1997) 0.79

Increased concentration of soluble E-selectin in the sera of breast cancer patients. Anticancer Res (1997) 0.79

Adhesion molecules involved in the trafficking of normal and malignant leukocytes. Invasion Metastasis (1992) 0.79

Corticosteroids and medroxyprogesterone acetate inhibit the induction of E-selectin on the vascular endothelium by MDA-MB-231 breast cancer cells. Anticancer Res (1996) 0.78

Role of SPan-1 antigen in adhesion of human colon cancer cells to vascular endothelium. Dig Dis Sci (1995) 0.78

Selectins: physiological and pathophysiological roles. Biochem Soc Trans (1997) 0.77

Novel endothelial cell activation factor(s) released from activated platelets which induce E-selectin expression and tumor cell adhesion to endothelial cells: a preliminary note. Biochem Biophys Res Commun (1994) 0.77

Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion. Jpn J Cancer Res (1994) 0.76

Tyrosine kinase-dependent regulation of L-selectin expression through the Leu-13 signal transduction molecule: evidence for a protein kinase C-independent mechanism of L-selectin shedding. J Immunol (1997) 0.76

Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma. Eur J Cancer (1997) 0.76

Kinetics of soluble TNF-receptors and soluble adhesion molecules ICAM-1, E-selectin and VCAM-1 under systemic rhTNF alpha therapy. Eur J Clin Invest (1996) 0.75

Surface carbohydrates involved in the adhesive interactions of metastatic cells. Biochem Soc Trans (1997) 0.75

Articles by these authors

B lymphocyte receptors and polyphosphoinositide degradation. Cell (1985) 2.66

Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis. Clin Exp Metastasis (1996) 1.22

CD44 in inflammation and metastasis. Glycoconj J (1997) 1.16

Relation between raised concentrations of fucose, sialic acid, and acute phase proteins in serum from patients with cancer: choosing suitable serum glycoprotein markers. J Clin Pathol (1985) 1.15

Hyaluronic acid secreted by mesothelial cells: a natural barrier to ovarian cancer cell adhesion. Clin Exp Metastasis (1995) 1.13

Anti-tumour activity of aprotinin. Br J Cancer (1974) 1.13

Levels of adenosine 3',5' cyclic monophosphate and guanosine 3',5' cyclic monophosphate in single urine specimens collected from a large population of healthy subjects. Ann Clin Biochem (1982) 1.11

Elevated levels of abnormally-fucosylated haptoglobins in cancer sera. Br J Cancer (1987) 1.08

The transport of plutonium, americium and curium in the blood of rats. Phys Med Biol (1968) 1.08

Expression of cell adhesion molecules on ovarian tumour cell lines and mesothelial cells, in relation to ovarian cancer metastasis. Cancer Lett (1995) 1.01

Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett (1992) 0.98

A novel flow cytometric assay for quantitating adherence of Helicobacter pylori to gastric epithelial cells. J Immunol Methods (1998) 0.95

Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasis. Br J Cancer (1991) 0.95

Radioiodination studies of tumour cell-surface proteins after different disaggregation procedures. Br J Cancer (1977) 0.94

The role of polyphosphoinositides and their breakdown products in A23187-induced release of arachidonic acid from rabbit polymorphonuclear leucocytes. Biochem J (1986) 0.93

Surface properties of the metastatic cell. Invasion Metastasis (1982) 0.92

Increased release of tumour cells by collagenase at acid pH: a possible mechanism for metastasis. Experientia (1979) 0.91

Phase I study of a five-day dose schedule of 4-Ipomeanol in patients with non-small cell lung cancer. Clin Cancer Res (1998) 0.90

The glycosylation of haptoglobin in rheumatoid arthritis. Clin Chim Acta (1993) 0.89

A simple, reproducible and cheap batch method for the analysis of serum glycoproteins using sepharose-coupled lectins and silver staining. Clin Chim Acta (1987) 0.89

Fucosylated forms of alpha-1-antitrypsin that predict unresponsiveness to chemotherapy in ovarian cancer. Br J Cancer (1988) 0.88

Reproducible and sensitive determination of charged oligosaccharides from haptoglobin by PNGase F digestion and HPAEC/PAD analysis: glycan composition varies with disease. Glycoconj J (1998) 0.87

gamma-Hexachlorocyclohexane stimulation of macrophage phospholipid hydrolysis and leukotriene production. Biochem Pharmacol (1984) 0.87

Effect of aprotinin on immunological resistance in tumour-bearing animals. Br J Cancer (1976) 0.86

Abnormally-fucosylated serum haptoglobins in patients with inflammatory joint disease. Clin Chim Acta (1989) 0.86

Enhanced malignant behaviour of cells treated with crude rat liver histone. Br J Cancer (1973) 0.86

Surface protein distributions in cells isolated from solid tumours and their metastases. Br J Cancer (1979) 0.85

Analyses of protein extracts of human breast cancers: changes in glycoprotein content linked to the malignant phenotype. Br J Cancer (1987) 0.85

Decreased branching, increased fucosylation and changed sialylation of alpha-1-proteinase inhibitor in breast and ovarian cancer. Clin Chim Acta (1995) 0.85

A multiwell lectin-binding assay using lotus tetragonolobus for measuring different glycosylated forms of haptoglobin. Clin Chim Acta (1989) 0.84

Parallel changes in the blood levels of abnormally-fucosylated haptoglobin and alpha 1,3 fucosyltransferase in relationship to tumour burden: more evidence for a disturbance of fucose metabolism in cancer. Cancer Lett (1992) 0.84

Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin Chim Acta (1994) 0.83

Plasma alpha-1-antitrypsin levels in early and late carcinoma of the cervix. Oncology (1976) 0.83

Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan. Clin Exp Metastasis (1999) 0.83

Differences in surface expression of WGA-binding proteins of cells from a lymphosarcoma and its liver metastases. Br J Cancer (1984) 0.82

A precise, rapid and sensitive in vitro assay to measure the adhesion of ovarian tumour cells to peritoneal mesothelial cells. Cancer Lett (1994) 0.82

Abnormally fucosylated haptoglobin as a marker for alcoholic liver disease but not excessive alcohol consumption or non-alcoholic liver disease. Clin Chim Acta (1993) 0.82

Cyclic GMP in urine to monitor the response to ovarian cancer to therapy. Br J Obstet Gynaecol (1982) 0.82

Serum alkaline phosphatase in rats with streptozotocin-induced diabetes. Horm Metab Res (1987) 0.81

The chemistry of lipid peroxidation metabolites: crosslinking reactions of malondialdehyde. Lipids (1986) 0.81

An improved ELISA for the determination of sialyl Lewis(x) structures on purified glycoconjugates. Glycoconj J (1996) 0.81

A comparison of the electrokinetic properties of metastasizing and non-metastasizing forms of a hamster lymphosarcoma. Exp Cell Biol (1980) 0.80

The binding of ConA and other lectins to surface glycoproteins: a comparison of a subcutaneous tumour and its liver metastases. Invasion Metastasis (1985) 0.80

Some effects of products from necrotic regions of tumours on the in vitro migration of cancer and peritoneal exudate cells. Int J Cancer (1980) 0.80

C.E.A. in gastric cancer. Lancet (1979) 0.79

Triamterene-induced acute interstitial nephritis. Lancet (1982) 0.79

An ultrasensitive technique for the analysis of glycoproteins using lectin blotting with enhanced chemiluminescence. Anal Biochem (1993) 0.78

A simple lectin-mediated cell-adhesion method for investigating the cell surface. Exp Cell Biol (1979) 0.78

Binding of ovarian cancer cells to immobilized hyaluronic acid. Glycoconj J (1997) 0.78

Binding of ovarian cancer cells to immobilized hyaluronic acid. Glycoconj J (1997) 0.78

The development of a performance indicator to objectively monitor the quality of care provided by an acute pain team. Anaesth Intensive Care (2000) 0.78

A simple, sensitive and rapid method for the estimation of cyclic AMP in urine using luciferase luminescence. Clin Chim Acta (1982) 0.78

TEEM-test studies on effect of aprotinin on in vitro response of cancer patients' lymphocytes to PPD. Br J Cancer (1978) 0.78

The growth and metastasis of four commonly used tumour lines implanted into eight different sites: evidence for site and tumour effects. Clin Exp Metastasis (1988) 0.78

A lectin method for investigating the glycosylation of nanogram amounts of purified glycoprotein. Glycoconj J (1997) 0.78

Effective treatment of a patient with an advanced carcinoma of the cervix with a combination of bromocriptine and aprotinin. Br J Clin Pract (1981) 0.77

Surface properties of cells isolated from non-metastasizing and metastasizing hamster lymphosarcomas. Br J Cancer (1980) 0.77

Do synovial fluid acute phase proteins from patients with rheumatoid arthritis originate from serum? Glycoconj J (1997) 0.77

Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. Clin Chim Acta (1991) 0.77

Surface modification and electrophoresis of normal and transformed BHK21 cells. J Cell Sci (1974) 0.77

Sulindac-induced acute interstitial nephritis. N Z Med J (1984) 0.76

Sialyl Lewis(x) expression on IgG in rheumatoid arthritis and other arthritic conditions: a preliminary study. Glycoconj J (1998) 0.75

Analysis of aprotinin-induced enhancement of metastasis of Lewis lung tumors in mice. Cancer Res (1981) 0.75

Urine cyclic nucleotide concentrations in cancer and other conditions; cyclic GMP: a potential marker for cancer treatment. J Clin Pathol (1982) 0.75

Studies of the sialylation and microheterogeneity of human serum alpha 1-acid glycoprotein in health and disease. Clin Chim Acta (1987) 0.75

Evaluation of hepatic venous balloon occluder to estimate portal pressure. Clin Invest Med (1990) 0.75

Serial use of aprotinin and incidence of allergic reactions. Curr Med Res Opin (1983) 0.75

A method for measurement of low levels of guanosine 3',5'-cylic monophosphate in blood plasma. Clin Chim Acta (1977) 0.75

Increased trypsin sensitivity of cell surface macromolecules after malignant transformation. Exp Cell Biol (1978) 0.75

The study of glycoconjugates in pathological processes. Glycoconj J (1995) 0.75

Minimum oxygen requirements during anaesthesia with the Triservice anaesthetic apparatus. A study of drawover anaesthesia in the young adult. Anaesthesia (1991) 0.75

Effect of unconjugated and conjugated phenol and uraemia on the synthesis of adenosine 3' :5' -cyclic monophosphate in rat brain homogenates. Clin Sci Mol Med (1978) 0.75

Serum enzyme changes during chemotherapy for ovarian cancer. Clin Biochem (1982) 0.75

Evaluation of 3,4-dinitrophenyl tetra-N-acetyl-beta-chitotetraoside as a substrate for the measurement of lysozyme in normal and pathological sera. Ann Clin Biochem (1979) 0.75

Cervical meningioma and lumbar stenosis: a case presenting as immobility. Aust N Z J Med (1997) 0.75

Variations in WGA-binding proteins in tumours growing in different implantation sites. Exp Cell Biol (1989) 0.75

SHIP BERI-BERI. Br Med J (1905) 0.75

The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells. Experientia (1980) 0.75

Studies on glomerular basement membrane in experimental diabetes using lectin histochemistry in Wistar rats. Diabetologia (1986) 0.75

Studies of lotus-extracted haptoglobin in inflammatory bowel disease. Biochem Soc Trans (1991) 0.75

Thymus-histone treated BHK21 cells; malignant characteristics in vitro but reduced tumorigenicity. Eur J Cancer (1974) 0.75

Increased nuclear size in BHK21 cells after treatment with non-toxic levels of calf thymus histones. Exp Cell Biol (1979) 0.75

A detailed study of the effects of in vitro interferon treatment on the growth of two variants of the B16 mouse melanoma in the lungs: evidence for non-specific effects. Clin Exp Metastasis (1990) 0.75

A preliminary study of serum class II levels in healthy individuals and bone-marrow transplant patients. Clin Chim Acta (1989) 0.75

Cyclic adenosine 3', 5' monophosphate: a possible indicator of premalignant changes in the large bowel. Ann Clin Biochem (1979) 0.75

Meningioma as an incidental finding in an intensive care unit. J R Nav Med Serv (1989) 0.75

Monosaccharide composition of haptoglobin purified from alcoholic cirrhotic and control sera determined by HPAE. Biochem Soc Trans (1993) 0.75

Objectivity in the assessment of equine welfare. Equine Vet J (2000) 0.75

Serum alpha-1-proteinase inhibitor with abnormal properties in ovarian cancer. Clin Chim Acta (1990) 0.75

Electrocorticographic activity during repeated vs continuous hypoxia in piglets. Brain Res Bull (1996) 0.75

Slot-blotting with enhanced chemiluminescence detection: an ultrasensitive technique for the quantitative analysis of proteins and glycoproteins. Biochem Soc Trans (1994) 0.75

Expression of Lewis x antigen on ovarian cancer cells is related to cell growth. Biochem Soc Trans (1994) 0.75